Free Trial

Prestige Consumer Healthcare (PBH) Earnings Date, Estimates & Call Transcripts

Prestige Consumer Healthcare logo
$67.58 +0.62 (+0.93%)
As of 03:38 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Prestige Consumer Healthcare Earnings Summary

Prestige Consumer Healthcare announced Q1 2026 earnings on August 7, 2025, reporting an EPS of $0.95, which missed analysts' consensus estimates of $1.01 by $0.06. Quarterly revenue fell 6.6% year-over-year to $249.53 million, below the consensus estimate of $260.71 million. With a trailing EPS of $4.26 and a P/E Ratio of 15.86, Prestige Consumer Healthcare's earnings are expected to grow 5.78% next year, from $4.50 to $4.76 per share.

Upcoming Q2
Earnings Date
Nov. 6Before Market OpensEstimated
Consensus EPS
(Aug. 7)
$1.01
Actual EPS
(Aug. 7)
$0.95 Missed By -$0.06
Actual Revenue
(Aug. 7)
$249.53M

Q1 2026 Earnings Resources

PBH Upcoming Earnings

Prestige Consumer Healthcare's next earnings date is estimated for Thursday, November 6, 2025, based on past reporting schedules.

Get Prestige Consumer Healthcare Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Prestige Consumer Healthcare and other key companies, straight to your inbox.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

PBH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PBH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Prestige Consumer Healthcare Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue Guidance
Q1 20253$0.86$0.86$0.86
Q2 20253$1.08$1.09$1.08
Q3 20253$1.16$1.21$1.19
Q4 20253$1.30$1.30$1.30
FY 2025 12 $4.40 $4.46 $4.43
Q1 20262$0.98$1.00$0.99
Q2 20262$1.19$1.22$1.21
Q3 20262$1.19$1.25$1.22
Q4 20262$1.29$1.40$1.35
FY 2026 8 $4.65 $4.87 $4.76
Q1 20271$1.25$1.25$1.25
Q2 20271$1.23$1.23$1.23
Q3 20271$1.29$1.29$1.29
Q4 20271$1.25$1.25$1.25

Prestige Consumer Healthcare Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/6/2025
(Estimated)
--------
8/7/2025Q1 2026$1.01$0.95 -$0.06$0.95$260.71M$249.53M
5/8/2025Q4 2025$1.30$1.32+$0.02$1.00$289.36M$296.52M
2/6/2025Q3 2025$1.18$1.22+$0.04$1.22$287.07M-
11/7/2024Q2 2025$1.09$1.09-$1.09$282.09M$283.79M
8/8/2024Q1 2025$0.86$0.90+$0.04$0.82$260.54M$267.10M
5/14/2024Q4 2024$1.14$1.02 -$0.12$1.06$287.42M$277.00M
2/8/2024Q3 2024$1.04$1.06+$0.02$1.06$280.25M$282.74M
11/2/2023Q2 2024$1.07$1.07-$1.07$285.13M$286.32M

Prestige Consumer Healthcare Earnings - Frequently Asked Questions

Prestige Consumer Healthcare has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 6th, 2025 based off last year's report dates. Learn more on PBH's earnings history.

Prestige Consumer Healthcare updated its FY 2026 earnings guidance on Thursday, August, 7th. The company provided EPS guidance of 4.500-4.580 for the period, compared to the consensus estimate of 4.770. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion.

In the previous quarter, Prestige Consumer Healthcare (NYSE:PBH) missed the analysts' consensus estimate of $1.01 by $0.06 with a reported earnings per share (EPS) of $0.95. Learn more on analysts' earnings estimate vs. PBH's actual earnings.

The conference call for Prestige Consumer Healthcare's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Prestige Consumer Healthcare's latest earnings report can be read online.
Read Transcript

Prestige Consumer Healthcare's earnings report can be found in their filing with the SEC.
View SEC filing

Prestige Consumer Healthcare (NYSE:PBH) has a recorded annual revenue of $1.14 billion.

Prestige Consumer Healthcare (NYSE:PBH) has a recorded net income of $214.60 million. PBH has generated $4.26 earnings per share over the last four quarters.

Prestige Consumer Healthcare (NYSE:PBH) has a trailing price-to-earnings ratio of 15.86 and a forward price-to-earnings ratio of 15.02. The price/earnings-to-growth ratio is 2.1.

Prestige Consumer Healthcare's earnings are expected to grow from $4.50 per share to $4.76 per share in the next year, which is a 5.78% increase.

More Earnings Resources from MarketBeat



This page (NYSE:PBH) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners